Rekombinanter ISR-alpha Antikörper (Extracellular)
Kurzübersicht für Rekombinanter ISR-alpha Antikörper (Extracellular) (ABIN5707973)
Target
Alle ISR-alpha Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- Extracellular
-
Verwendungszweck
- Recombinant Insulin Receptor alpha Antibody (azide and preservative free)
-
Aufreinigung
- Protein A affinity chromatography
-
Immunogen
- A recombinant partial protein from the extracellular region of the protein was used as the immunogen for the recombinant Insulin Receptor alpha antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the recombinant Insulin Receptor alpha antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant Insulin Receptor alpha antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- ISR-alpha (Insulin Receptor alpha (ISR-alpha))
-
Andere Bezeichnung
- Insulin Receptor alpha
-
Hintergrund
- The insulin receptor (INSR) is a heterodimeric protein complex that has an intracellular β, subunit and an extracellular α, subunit, which is disulfide-linked to a transmembrane segment. The insulin ligand binds to the INSR and initiates molecular signaling pathways that promote glucose uptake in cells and glycogen synthesis. Insulin binding to INSR induces phosphorylation of intra-cellular tyrosine kinase domains and recruitment of multiple SH2 and SH3 domain-containing intracellular proteins that serve as signaling intermediates for pleiotropic effects of insulin. Type 1 diabetes is an autoimmune condition of the endocrine pancreas that results in destruction of insulin secreting cells and a progressive loss in insulin-sensitive glucose uptake by cells.
-
UniProt
- P06213
Target
-